Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 25, 2022 07:00 ET | Source: Miromatrix Medical Inc.

Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology

EDEN PRAIRIE, Minn., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
August 23, 2022 07:00 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase

EDEN PRAIRIE, Minn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
August 15, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Aug. 15, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
August 10, 2022 07:00 ET | Source: Miromatrix Medical Inc.

Miromatrix Appoints Jack Lake, M.D., as Medical Director

EDEN PRAIRIE, Minn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
August 01, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix to Report Second Quarter 2022 Financial Results

EDEN PRAIRIE, Minn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
July 05, 2022 07:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Applauds the FDA for Its Continued Commitment to the Field of Organ Transplant

EDEN PRAIRIE, Minn., July 05, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 31, 2022 16:30 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in the 2022 American Transplant Congress

EDEN PRAIRIE, Minn., May 31, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 25, 2022 16:30 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference

EDEN PRAIRIE, Minn., May 25, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 17, 2022 16:39 ET | Source: Miromatrix Medical Inc.

Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference

EDEN PRAIRIE, Minn., May 17, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...
May 16, 2022 16:01 ET | Source: Miromatrix Medical Inc.

Miromatrix Reports First Quarter 2022 Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 16, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to...